Catalent Adds Clinical Supplies Capacity
A $5.5-million expansion at its Philadelphia, PA clinical supplies facility gives Catalent additional packaging and storage capacity.
Catalent Pharma Solutions has completed a $5.5-million-expansion program at its 200,000-sq.-ft. site in Philadelphia, PA, to provide additional clinical packaging and storage capacity. The facility is one of the largest sites in Catalent’s global clinical supply network, the company reported in an April 12, 2018 announcement.
The investment adds 40% more pallet space for refrigerated and ambient clinical storage, additional cold chain packaging areas, and a clinical label control area. The building also features a campus-wide environmental monitoring and building management system.
“The expansion not only allows us to meet the demand for additional capacity to serve large-scale clinical studies today, but also provides the space necessary for future growth,” said Albert Quintero, general manager, Clinical Supply Services.
Source: Catalent Pharma Solutions
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
